Rafiq Hasan

Director at Oxular

Rafiq is the CEO of EXACT Therapeutics, a clinical-stage Anglo-Norwegian biotech company. An MD by training, Rafiq has 25 years in the pharma industry globally. As Senior Vice President and Global Head of Ophthalmology at Bayer, he grew the business of Eylea® from launch to over $2.5bn in five years, including its launch in five indications in three years.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Oxular

Oxular is developing disruptive treatments for retinal diseases. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye.


Industries

Employees

11-50

Links